Militia Capital Partners, LP Prelude Therapeutics Inc Transaction History

Militia Capital Partners, LP

  • $212 Billion
  • Q3 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jun 05, 2025
BUY
$0.64 - $1.39 $2,752 - $5,977
4,300 New
4,300 $3.3 Million

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $55.6M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Militia Capital Partners, LP Portfolio

Follow Militia Capital Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Militia Capital Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Militia Capital Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email